Incannex Healthcare clinical trials we track

Check company identity source

Phase 2 / 3 1 trial

TrialDrugs studiedStatusPrimary completion
RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSANCT06146101Acetazolamide, Dronabinol, IHL-42X (Optimal Dose), IHL-42X High Dose and 1 moreCompleted2025-05-20Actual

Phase 2 2 trials

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 560 participants (planned). After: 121 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Dec 2026. After: 20 May 2025.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source